To be manufactured at Ashland cGMP plant in Wilmington, US
Ashland Specialty Ingredients, a division of Ashland Inc, has announced an expanded tablet film coatings portfolio as part of its aim to expand its pharmaceutical excipients business.
The new product line integrates the Advantia coating systems line formerly marketed by International Specialty Products Inc, which Ashland recently acquired, with Ashland’s Aquarius coating systems products. The Wilmington, Delaware, US-based firm says it now offers one of the broadest product lines in the industry.
All tablet coating systems will be manufactured at Ashland’s cGMP plant in Wilmington.
‘Combining these two product lines under the Aquarius brand, while applying our polymer know-how to the formulation of ready-to-use film coatings, has led to an extensive tablet coating systems portfolio,’ said Timothy Bee, business director, Pharmaceutical and Nutrition Specialties, Ashland Specialty Ingredients.
‘Aquarius coating systems will include aesthetic and functional coating solutions for the global pharmaceutical and nutraceutical industries. Our offering includes the full spectrum of colours in addition to barrier systems against moisture, odours and tastes, as well as sustained- and delayed-release coatings.’
Ashland has full technical service capabilities to support the expanded Aquarius coating systems line with labs in the US, Mexico, Brazil, Argentina, Turkey, India and China.
‘Our technical experts at these facilities work on customised coating systems, colour matching and troubleshooting, and can also provide tablet formulation development or on-site trial support,’ said Tom Durig, director, Pharmaceutical and Nutrition Specialties R&D, Ashland Specialty Ingredients.
‘We’re committed to growing our global technical presence aggressively and continuing to invest in our technical organisation and capabilities to serve the global tablet coatings market better.’